Please login to the form below

Not currently logged in
Email:
Password:

Shire lines up Advanced BioHealing deal

Shire is to acquire Advanced BioHealing, a US-based regenerative medicine company, for $750m in cash

Shire has acquired Advanced BioHealing, a US-based regenerative medicine company, for $750m in cash. The deal will see Shire own the global rights for DERMAGRAFT, a regenerative bio-engineered skin substitute indicated for use in the treatment of diabetic foot ulcers greater than six weeks in duration, and will continue to invest in the development of new indications and new geographies, pending regulatory approvals.  

Mike Cola, president of Shire's Specialty Pharmaceuticals business, said: "This acquisition is a strong and complementary strategic fit for Shire. We will invest in the strengths of Advanced BioHealing's specialist commercial team, its manufacturing and its product development.

“We believe there's an opportunity to create more value from DERMAGRAFT and Advanced BioHealing's proprietary technology and that with Advanced BioHealing's team joining Shire, we can build Advanced BioHealing into an exciting new business providing regenerative medicine for patients' unmet needs."

The deal is subject to customary conditions, including obtaining anti-trust clearances.

18th May 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics